Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,548 | 18,009 | 19,208 | 19,986 | 0 |
| TOTAL | $17,249 | $18,964 | $20,500 | $21,654 | $0 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $17,249 | $18,964 | $20,500 | $21,654 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 83 | 43 | 494 | 110 | 0 |
| Accrued Expenses | 3 | 7 | 114 | 132 | 0 |
| TOTAL | $86 | $50 | $608 | $242 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $86 | $50 | $608 | $242 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,345 | 23,345 | 23,345 | N/A | N/A |
| Common Shares | 23 | 23 | 23 | 23 | 0 |
| Retained earnings | -43,147 | -41,271 | -40,198 | -38,644 | 0 |
| TOTAL | $17,163 | $18,914 | $19,893 | $21,412 | $0 |
| Total Liabilities And Equity | $17,249 | $18,964 | $20,500 | $21,654 | $0 |